BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 8288186)

  • 1. Insights into how adeno-squamous transition drives KRAS inhibitor resistance.
    Hu F; Lito P
    Cancer Cell; 2024 Mar; 42(3):330-332. PubMed ID: 38471455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
    Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
    Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and immunoblot analyses of ras-p21 expression in lung carcinomas.
    Koshiishi Y; Noguchi M; Nakajima T; Hirohashi S; Shimosato Y; Hayata Y
    Acta Pathol Jpn; 1989 Oct; 39(10):643-7. PubMed ID: 2686349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
    Bastide K; Ugolin N; Levalois C; Bernaudin JF; Chevillard S
    Lung Cancer; 2010 Apr; 68(1):1-9. PubMed ID: 20004040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The KRAS oncogene: past, present, and future.
    Kranenburg O
    Biochim Biophys Acta; 2005 Nov; 1756(2):81-2. PubMed ID: 16269215
    [No Abstract]   [Full Text] [Related]  

  • 9. [A study on P21(ras) in human lung cancer and body fluid of cancer patients].
    Lin X; Shu X; Sun Z; Zhao J; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):233-6. PubMed ID: 8288186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras p21 expression and activity in lung and lung tumors.
    Ramakrishna G; Sithanandam G; Cheng RY; Fornwald LW; Smith GT; Diwan BA; Anderson LM
    Exp Lung Res; 2000 Dec; 26(8):659-71. PubMed ID: 11195463
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.